Concepedia

Matthieu Leuillier

ML

Statistics

Publications

4

Citations

101

H-Index

4

Active since

2019

Affiliations

Inserm(Current)

Université de Rouen Normandie

Centre Hospitalier Universitaire de Rouen

Normandie Université

University of California, Davis

Matthieu Leuillier is an author at Inserm specializing in epoxide hydrolase activity, phosphatase inhibition, and pharmacology.

Publications per year

2019–2022

4

Publications

4

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain

Jan S. Kramer, Stefano Woltersdorf, Thomas Duflot et al. · Journal of Medicinal Chemistry · 2019 · 46 citations · Full text

, , +17

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients

Thomas Duflot, Lucile Moreau‐Grangé, Clothilde Roche et al. · Cardiovascular Diabetology · 2019 · 21 citations · Full text

, , +17

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury

Matthieu Leuillier, Thomas Duflot, Séverine Ménoret et al. · Journal of Advanced Research · 2022 · 21 citations · Full text

, , +17

Beneficial Effects of Remifentanil Against Excitotoxic Brain Damage in Newborn Mice

Clément Chollat, Maryline Lecointre, Matthieu Leuillier et al. · Frontiers in Neurology · 2019 · 13 citations · Full text

, , +15

1–4 of 4